Recent work has shown that blocking endogenous cathepsin inhibitors, such as cystatin B, decreases Aβ accumulation, autophagic-lysosomal pathology, and cognitive improvement in AD mice [240]. This evidence concerns the gene CTSS and Alzheimer disease.